Iterum Therapeutics plc (ITRMF) Non-Current Deferred Tax Liability (2018 - 2019)

Iterum Therapeutics has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $24000.0 in Q4 2019.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 51.02% year-over-year to $24000.0 in Q4 2019; TTM through Dec 2019 was $24000.0, a 51.02% decrease from a year earlier, with the FY2019 full-year figure at $24000.0, down 51.02% from the prior year.
• Non-Current Deferred Tax Liability was $24000.0 for Q4 2019 at Iterum Therapeutics, down from $49000.0 in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $49000.0 in Q4 2018, with the low at $24000.0 in Q4 2019.